57:48

Sterility and Alternative Sterility Testing

44:11

USP 795 Updates and Cultivating a Culture of Quality within Your Team

01:02:18

Today’s USP 797: A Functional Approach to Quality Sterile Compounding

54:01

Beyond The Survey Top Findings and How to Implement Change in Your Pharmacy

59:41

Rapid Sterility Testing: An Alternative Microbiological Method

58:30

USP 51 Antimicrobial Effectiveness Testing & USP 71 Sterility Testing When, Why, and How

01:01:11

Understanding USP 797 Microbiology Testing Requirements

01:03:20

Compounding Lab Design and Engineering Considerations per USP 800 Guidelines

01:01:36

The Itch You Cannot Scratch: Veterinary Dermatology

01:03:53

Stability Testing Science and Compliance

52:54

QCS Session #9 - Panel Discussion

59:51

QCS Session #2 - Pharmacist/Provider/Patient Triad: A Multidisciplinary Approach to Patient Care

43:21

QCS Session #1 -NABP Implementation of the FDA Compounding MOU

42:58

QCS Session #8 - Sterility Assurance using Sterile Compounding Automation and Technology

53:21

QCS Session #7 - API or Approved Product: Where do we start with veterinary compounds?

57:19

QCS Session #6 - Cleanroom Certification - Digging Deeper

43:55

QCS Session #4 - Regulatory and Quality Considerations in the Selection of API

01:10:24

QCS Session #3 - Quality Compounding and Clinical Pharmaceutics

45:50

QCS Session #5 - Root Cause of Stability Failures

01:00

How Can Attendees Engage in QCS

02:13

What are Important Topics in the Industry Today?

03:04

QCS: Regulatory and Quality Considerations in the Selection of Active Pharmaceutical Ingredients

01:58

Happy National Pharmacy Week

01:53

Quality Compounding Summit: What Session Are You Most Excited About?

01:36

QCS Session 2: Pharmacist/Provider/Patient Triad: A Multidisciplinary Approach to Patient Care

02:09

Quality Compounding Summit

54:02

Raw Materials Revealed

37:11

A Pharmacist's Prescription for Bringing in New Customers

03:43

An Inside Look at ARL's Rapid Sterility Test

01:02:12

Insurance Considerations for Pharmacists and Professional Liability in Compounding

01:10

ARL Rapid Sterility Testing

01:10

SpecRx: ARL Rapid Sterility Testing - 20Ways Winter Hospital 2020

55:25

COVID-19 Testing and Therapeutics

58:54

Minor Chapters Major Impacts: What USP 51, 61 and 1207 Mean for Your Practice

01:01:34

More Than Selling Compounds! Webinar

04:55

First Do No Harm: Considerations of Safety and Efficacy Factors for Delivery of Drugs to the Eye

01:10

Insurance Considerations for Pharmacists and Professional Liability in Compounding

02:46

Future Technology and Automation in Pharmaceutical Compounding

01:33

Innovative Approaches to Implementing USP Compounding Standards

01:36

Minor Chapters, Major Impacts: What USP 51, 61 and 1207 Mean for Your Practice

43:09

Stability Testing: Science and Compliance

56:33

Rapid Sterility Testing Strategies for Compounded Sterile Preparations

59:48

Discover New Business Opportunities for Your Pharmacy

45:26

Rapid Sterility Testing

58:09

USP 800 Update – What is the current status and how do pharmacists proceed?

01:00:46

Beyond Use Date Strategies for Compounded Sterile Preparations

59:31

USP General Chapters and Compounded Monograph Chapters: Best Practices and Regulatory Guidance

02:40

ARL Bio Pharma's Cleanroom

52:05

Medical Marijuana (THC and CBD) Pharmacology, Regulation, and Pharmacy Considerations

50:39

The Practical Use of the USP as a Primary Reference Resource in Compounded Formulations

01:00:23

Stability Studies: The Architecture Behind Establishing a Beyond Use Date

59:07

Stability Indicating Methods

56:39

Microbiology Testing: USP requirements for Sterile and Nonsterile Preparations

59:15

Extending Beyond Use Dates for Compounded Preparations

51:39

An Inside Look at USP 71

59:27

Extending Beyond Use Dating and Release Testing

00:21

Quality Compounding Summit www.qcsummitrx.org